April 20, 2014 6:00 PM ET

Healthcare Providers and Services

Company Overview of Memorial Sloan-Kettering Cancer Center

Company Overview

Memorial Sloan-Kettering Cancer Center, a cancer hospital, provides cancer treatment services. It offers adult and pediatric cancer care services; specialized treatments and services, including adult blood and marrow stem cell transplantation, pediatric blood and marrow transplantation, and pathology consulting; and symptom management services, such as integrative medicine, palliative care and pain management, rehabilitation, dermatologic health, and cognitive testing. The company also provides services in the areas of counseling, dermatology, fertility, genetic testing and counseling, integrative medicine, nutrition, rehabilitation, resources for life after cancer program, sexual health, an...

1275 York Avenue

New York, NY 10065

United States

Founded in 1884





Key Executives for Memorial Sloan-Kettering Cancer Center

Chief Executive Officer and President
Age: 60
Senior Vice President of Finance
Chief Investment Officer and Vice President
Chief Information Officer and Vice President of Information Systems
Senior Vice President and General Counsel
Compensation as of Fiscal Year 2013.

Memorial Sloan-Kettering Cancer Center Key Developments

Memorial Sloan-Kettering Cancer Center Presents at Healthcare & Real Estate 2014, Apr-08-2014

Memorial Sloan-Kettering Cancer Center Presents at Healthcare & Real Estate 2014, Apr-08-2014 . Venue: The McGraw Hall, McGraw Hill Executive Suite, 1221 Avenue of the Americas, 50th Floor, New York, NY 10036, United States.

Memorial Sloan Kettering and Eureka Therapeutics Signs Licensing Agreement with Novartis

Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. announced that it have entered into a licensing agreement with Novartis AG for the development and commercialization of ESK1, a preclinical stage monoclonal antibody for the treatment of leukemia and other cancers. Memorial Sloan Kettering is a cancer hospital that provides cancer care services, while Eureka Therapeutics is a biotechnology company that focuses on the discovery of human antibody drugs for the treatment of cancer. Both the companies are based in the United States. The ESK1 developed by Eureka Therapeutics and Memorial Sloan-Kettering Cancer Center. Under the terms of the agreement, Eureka Therapeutics and Memorial Sloan-Kettering will receive an up front payment and potential future payments upon achievement of development, regulatory and sales milestones, and annual net sales royalty payments. Novartis will fund and execute all additional development and commercialization activities.

Memorial Sloan Kettering Cancer Center Presents at Life Sciences Summit 2013, Nov-20-2013 01:15 PM

Memorial Sloan Kettering Cancer Center Presents at Life Sciences Summit 2013, Nov-20-2013 01:15 PM. Venue: Convene - Midtown East, 730 Third Avenue (Between East 45th and 46th Streets), 17th Floor, New York, NY 10017, United States. Speakers: Clifford A Hudis, Chief, Breast Cancer Medicine Service.

Similar Private Companies By Industry

Company Name Region
Winter Haven Hospital United States
Healthsouth Rehabilitation Hospital of Sarasota L.P. United States
Borgess Health Alliance, Inc. United States
The Cape Coral/Ft. Myers Endoscopy ASC, LLC United States
Allegiance Health Services, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Memorial Sloan-Kettering Cancer Center, please visit www.mskcc.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.